Ready to launch your business? Get started with the commerce platform made for entrepreneurs. Shopify is specially designed to help you start, run and grow your business with easy customizable themes that let you build your brand, marketing tools that get your products out there. Integrated shipping solutions that actually save you time. From startups to scaleups, online, in person, and on the go. Shopify is made for

entrepreneurs like you. Sign up for your $1 a month trial at Shopify.com slash setup.

Here's your morning brief for Monday, November 10th. I'm Caitlin McCabe for the Wall Street Journal.

The Senate took the first step last night toward ending the longest government shutdown in

U.S. history after eight members of the Democratic caucus joined Republicans in voting to advance

a spending measure aimed at reopening the government. Affordable Care Act subsidies have been a

point of contention during the shutdown,

but a key development to ease the stalemate came when Senate Republicans propose that some

health care funding be provided directly to households instead.

The Senate's next big step is to amend the measure and send it back to the House of Representatives

before being signed by President Trump, a process that could take several days.

That said, markets in Asia and Europe have rallied on the prospect of the shutdown ending, with U.S. stock futures also pointing firmly higher.

A federal appeals court has denied the Trump administration's bid to avoid fully funding federal food assistance benefits for this month.

The ruling came in just before midnight last night and means the government will have to make the payments under the supplemental nutrition assistance program or snap within 48 hours unless the Supreme Court intervenes.

Court proceedings may not factor in if the shutdown ends and funding for SNAP comes back.

And Novo Nordisk shares are gaining today after the Danish drug maker withdrew from a bidding war with

Pfizer for U.S. obesity startup MetS. Pfizer agreed late Friday to

buy MetSara in a deal that could be worth more than $10 billion following a heated takeover battle

with Novo. And we have a lot more coverage of the day's news on the WSJ's What's News podcast.

You can add it to your playlist on your smart speaker

or listen and subscribe wherever you get your podcasts.